73 related articles for article (PubMed ID: 9605010)
1. The intermediate filaments and prognostically oriented morphological classification in ductal breast carcinoma.
Rejthar A; Nenutil R
Neoplasma; 1997; 44(6):370-3. PubMed ID: 9605010
[TBL] [Abstract][Full Text] [Related]
2. [Demonstration and possible prognostic value of the nucleolar organizer region (NOR), the microtubule-associated proteins 1A/1B (MAP) and the intermediate filaments vimentin and cytokeratin 19 in invasive ductal breast carcinoma].
Friedrich K; Sturm U; Dimmer U; Flössel C
Zentralbl Pathol; 1994 Mar; 140(1):61-71. PubMed ID: 7515675
[TBL] [Abstract][Full Text] [Related]
3. Co-expression of cytokeratin and vimentin intermediate filament proteins in benign and neoplastic breast epithelium.
Raymond WA; Leong AS
J Pathol; 1989 Apr; 157(4):299-306. PubMed ID: 2469782
[TBL] [Abstract][Full Text] [Related]
4. [The prognosis of ductal invasive breast carcinoma in histopathology].
Rejthar A; Nenutil R
Cesk Patol; 1996 Dec; 32(4):123-31. PubMed ID: 16841444
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical identification of basal-type cytokeratins in invasive ductal breast carcinoma--relation with grade, stage, estrogen receptor and HER2.
Kusińska R; Potemski P; Jesionek-Kupnicka D; Kordek R
Pol J Pathol; 2005; 56(3):107-10. PubMed ID: 16334976
[TBL] [Abstract][Full Text] [Related]
6. Cytokeratin 8 immunostaining pattern and E-cadherin expression distinguish lobular from ductal breast carcinoma.
Lehr HA; Folpe A; Yaziji H; Kommoss F; Gown AM
Am J Clin Pathol; 2000 Aug; 114(2):190-6. PubMed ID: 10941333
[TBL] [Abstract][Full Text] [Related]
7. Apocrine ductal carcinoma in situ of the breast: histologic classification and expression of biologic markers.
Leal C; Henrique R; Monteiro P; Lopes C; Bento MJ; De Sousa CP; Lopes P; Olson S; Silva MD; Page DL
Hum Pathol; 2001 May; 32(5):487-93. PubMed ID: 11381366
[TBL] [Abstract][Full Text] [Related]
8. [Immunohistochemical analysis of 42 renal cell carcinomas and one oncocytoma with mono- and polyclonal antibodies against vimentin and cytokeratin].
Beham A; Ratschek M; Zatloukal K; Denk H; Lackinger E
Verh Dtsch Ges Pathol; 1989; 73():392-5. PubMed ID: 2482624
[TBL] [Abstract][Full Text] [Related]
9. Vimentin--a new prognostic parameter in breast carcinoma?
Raymond WA; Leong AS
J Pathol; 1989 Jun; 158(2):107-14. PubMed ID: 2547048
[TBL] [Abstract][Full Text] [Related]
10. Expression of cytokeratin markers, ER-alpha, PR, HER-2/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the breast.
Steinman S; Wang J; Bourne P; Yang Q; Tang P
Ann Clin Lab Sci; 2007; 37(2):127-34. PubMed ID: 17522367
[TBL] [Abstract][Full Text] [Related]
11. Correlation between type and grade of ductal carcinoma in situ and concomitant invasive ductal carcinoma of the breast.
Rudnicka L; Stachura J
Pol J Pathol; 2000; 51(3):137-43. PubMed ID: 11247396
[TBL] [Abstract][Full Text] [Related]
12. Breast infiltrating ductal carcinoma: analysis of hormone, HER-2 receptors and Ki-67 proliferation marker.
Mustać E; Zamolo G; Petković M; Dordević G; Radić J; Grgurević E; Batinac T
Coll Antropol; 2008 Sep; 32(3):741-6. PubMed ID: 18982746
[TBL] [Abstract][Full Text] [Related]
13. Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast.
Kominsky SL; Argani P; Korz D; Evron E; Raman V; Garrett E; Rein A; Sauter G; Kallioniemi OP; Sukumar S
Oncogene; 2003 Apr; 22(13):2021-33. PubMed ID: 12673207
[TBL] [Abstract][Full Text] [Related]
14. Morphology and intermediate filament composition of human mammary epithelial cells treated with stable butyrate derivative.
Planchon P; Magnien V; Ronco G; Villa P; Brouty-Boye D
Anticancer Res; 1992; 12(6B):2315-20. PubMed ID: 1284203
[TBL] [Abstract][Full Text] [Related]
15. Undifferentiated carcinoma of the pancreas: analysis of intermediate filament profile and Ki-ras mutations provides evidence of a ductal origin.
Hoorens A; Prenzel K; Lemoine NR; Klöppel G
J Pathol; 1998 May; 185(1):53-60. PubMed ID: 9713360
[TBL] [Abstract][Full Text] [Related]
16. Intracellular distribution of intermediate filaments in vimentin-positive gastric carcinomas: confocal laser scanning microscopy using formalin-fixed paraffin-embedded specimens.
Utsunomiya T; Yao T; Tamiya S; Tsuneyoshi M
Pathol Res Pract; 2002; 198(2):69-76. PubMed ID: 11928867
[TBL] [Abstract][Full Text] [Related]
17. Breast carcinoma in women 35 years and younger: a pathological study.
Fernandopulle SM; Cher-Siangang P; Tan PH
Pathology; 2006 Jun; 38(3):219-22. PubMed ID: 16753742
[TBL] [Abstract][Full Text] [Related]
18. [Medullary carcinoma of the breast. Co-expression of keratin intermediate filaments and protein S-100 in tumor cells].
Puzzo L; Lanzafame S
Pathologica; 1989; 81(1074):433-9. PubMed ID: 2483260
[TBL] [Abstract][Full Text] [Related]
19. Grading system for lymph vessel tumor emboli for prediction of the outcome of invasive ductal carcinoma of the breast.
Hasebe T; Yamauchi C; Iwasaki M; Ishii G; Wada N; Imoto S
Hum Pathol; 2008 Mar; 39(3):427-36. PubMed ID: 18261627
[TBL] [Abstract][Full Text] [Related]
20. Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.
Rakha EA; Putti TC; Abd El-Rehim DM; Paish C; Green AR; Powe DG; Lee AH; Robertson JF; Ellis IO
J Pathol; 2006 Mar; 208(4):495-506. PubMed ID: 16429394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
